Urso 250 Related Published Studies
Well-designed clinical trials related to Urso 250 (Ursodiol)
Efficacy and safety of ursodeoxycholic acid in primary, type IIa or IIb hypercholesterolemia: A multicenter, randomized, double-blind clinical trial. [2008.08.12]
Clinical Trial: Randomized controlled trial of zidovudine and lamivudine for patients with primary biliary cirrhosis stabilized on ursodiol. [2008.07.09]
Ursodeoxycholic acid treatment in preterm infants: a pilot study for the prevention of cholestasis associated with total parenteral nutrition. [2008.02]
Randomized controlled trial of total immunosuppression withdrawal in liver transplant recipients: role of ursodeoxycholic acid. [2007.06.27]
Ursodeoxycholic acid improves muscle contractility and inflammation in symptomatic gallbladders with cholesterol gallstones. [2007.06]
Randomized placebo-controlled trial of ursodeoxycholic acid with vitamin e in nonalcoholic steatohepatitis. [2006.12]
Ursodeoxycholic acid exerts no beneficial effect in patients with symptomatic gallstones awaiting cholecystectomy. [2006.06]
[Ursodeoxycholic acid, S-adenosyl-L-methionine and their combinations in the treatment of gestational intrahepatic cholestasis (ICP)] [2006.03]
Randomized prospective comparative study of ursodeoxycholic acid and S-adenosyl-L-methionine in the treatment of intrahepatic cholestasis of pregnancy. [2006]
Intrahepatic cholestasis of pregnancy: a randomized controlled trial comparing dexamethasone and ursodeoxycholic acid. [2005.12]
High-dose ursodeoxycholic acid in primary sclerosing cholangitis: a 5-year multicenter, randomized, controlled study. [2005.11]
Methotrexate (MTX) plus ursodeoxycholic acid (UDCA) in the treatment of primary biliary cirrhosis. [2005.11]
Short-term ursodeoxycholic acid treatment improves gallbladder bile turnover in gallstone patients: a randomized trial. [2005.10]
Efficacy and safety of ursodeoxycholic acid versus cholestyramine in intrahepatic cholestasis of pregnancy. [2005.09]
Complementary stimulation of hepatobiliary transport and detoxification systems by rifampicin and ursodeoxycholic acid in humans. [2005.08]
Phase III trial of ursodeoxycholic acid to prevent colorectal adenoma recurrence. [2005.06.01]
Bioequivalence of a new liquid formulation of ursodeoxycholic acid (Ursofalk suspension) and Ursofalk capsules measured by plasma pharmacokinetics and biliary enrichment. [2005.03.15]
[Effect of ursodeoxycholic acid combined with statins in hypercholesterolemia treatment: a prospective clinical trial] [2004.12]
Metronidazole and ursodeoxycholic acid for primary sclerosing cholangitis: a randomized placebo-controlled trial. [2004.12]
A prospective, randomized-controlled pilot study of ursodeoxycholic acid combined with mycophenolate mofetil in the treatment of primary sclerosing cholangitis. [2004.11.01]
[Prevention of clogging of biliary stents by administration of levofloxacin and ursodeoxycholic acid] [2004.11]
Ursodeoxycholic acid treatment in IBD-patients with colorectal dysplasia and/or DNA-aneuploidy: a prospective, double-blind, randomized controlled pilot study. [2004.09]
Ursodeoxycholic acid does not affect ethinylestradiol bioavailability in women taking oral contraceptives. [2004.09]
[Menthol in the adjuvant treatment of gallbladder stones fragmented by ESWL as an option for reducing doses of urso- and chenodeoxycholic acid] [2004.06.15]
Results of a phase I multiple-dose clinical study of ursodeoxycholic Acid. [2004.05]
A randomized controlled trial of colchicine plus ursodiol versus methotrexate plus ursodiol in primary biliary cirrhosis: ten-year results. [2004.04]
Ursodeoxycholic acid decreases viscosity and sedimentable fractions of gallbladder bile in patients with cholesterol gallstones. [2004.03]
Ursodeoxycholic acid for treatment of nonalcoholic steatohepatitis: results of a randomized trial. [2004.03]
Prolonged follow-up of patients in the U.S. multicenter trial of ursodeoxycholic acid for primary biliary cirrhosis. [2004.02]
A randomised controlled trial of ursodeoxycholic acid and S-adenosyl-l-methionine in the treatment of gestational cholestasis. [2004.01]
Treatment with ursodeoxycholic acid is associated with weight gain in patients with primary biliary cirrhosis. [2003.08]
A randomized double-blind study of the short-time treatment of obese patients with nonalcoholic fatty liver disease with ursodeoxycholic acid. [2003.06]
Effect of ursodeoxycholic acid on cholesterol absorption and metabolism in humans. [2003.05]
Effects of ursodeoxycholic acid (ursodiol) treatment on chronic viral hepatitis in heart transplant patients: results of a prospective, double-blind, placebo-randomized study. [2003.04.15]
Ursodeoxycholic acid as a chemopreventive agent in patients with ulcerative colitis and primary sclerosing cholangitis. [2003.04]
A randomized controlled trial of ursodeoxycholic acid in patients with alcohol-induced cirrhosis and jaundice. [2003.04]
Does ursodeoxycholic acid change the proliferation of the colorectal mucosa?. A randomized, placebo-controlled study. [2003]
Prevention of gallstones by ursodeoxycholic acid after cardiac surgery. [2003]
Improvement of alanine aminotransferase by administration of suplatast tosilate plus ursodeoxycholic acid in patients with resistance to ursodeoxycholic acid monotherapy on hepatitis C virus-related chronic liver disease. [2002.10]
Results of long-term ursodiol treatment for patients with primary biliary cirrhosis. [2002.10]
Ursodeoxycholic acid for the prevention of hepatic complications in allogeneic stem cell transplantation. [2002.09.15]
Changes in bile acid composition and effect on cytolytic activity of fecal water by ursodeoxycholic acid administration: a placebo-controlled cross-over intervention trial in healthy volunteers. [2002.08]
Intestinal absorption and biliary secretion of ursodeoxycholic acid and its taurine conjugate. [2002.08]
Ursodeoxycholic acid for primary biliary cirrhosis: final results of a 12-year, prospective, randomized, controlled trial. [2002.08]
An electron microscopic and morphometric study of ursodeoxycholic effect in primary biliary cirrhosis. [2002.06]
Hepatic apolipoprotein A-I gene expression in patients with cholesterol gallstones treated with ursodeoxycholic acid. [2002.04]
Primary biliary cirrhosis with additional features of autoimmune hepatitis: response to therapy with ursodeoxycholic acid. [2002.02]
A randomized trial of heparin plus ursodiol vs. heparin alone to prevent hepatic veno-occlusive disease after hematopoietic stem cell transplantation. [2002.01]
A preliminary trial of high-dose ursodeoxycholic acid in primary sclerosing cholangitis. [2001.10]
Ten-year combination treatment with colchicine and ursodeoxycholic acid for primary biliary cirrhosis: a double-blind, placebo-controlled trial on symptomatic patients. [2001.09]
Ofloxacin and ursodeoxycholic acid versus ursodeoxycholic acid alone to prevent occlusion of biliary stents: a prospective, randomized trial. [2001.06]
High-dose ursodeoxycholic acid as a therapy for patients with primary sclerosing cholangitis. [2001.05]
Ursodeoxycholic acid alone or with chenodeoxycholic acid for dissolution of cholesterol gallstones: a randomized multicentre trial. The British-Italian Gallstone Study group. [2001.01]
Multicentre randomized placebo-controlled trial of ursodeoxycholic acid with or without colchicine in symptomatic primary biliary cirrhosis. [2000.12]
The effect of ursodeoxycholic acid therapy on liver fibrosis progression in primary biliary cirrhosis. [2000.12]
Ursodeoxycholic acid does not interfere with in vivo Helicobacter pylori colonization. [2000.11]
Bioavailability of four ursodeoxycholic acid preparations. [2000.09]
Budesonide or prednisone in combination with ursodeoxycholic acid in primary sclerosing cholangitis: a randomized double-blind pilot study. Belgian-Dutch PSC Study Group. [2000.08]
[Ursodeoxycholic acid in the therapy of chronic hepatitis after treatment with interferon] [2000.07]
Randomized trial of interferon-alpha plus ursodeoxycholic acid versus interferon plus placebo in patients with chronic hepatitis C resistant to interferon. [2000.06]
Efficacy of ursodeoxycholic acid in association with alpha-interferon for chronic hepatitis C in alpha-interferon non-responder patients. [2000.05]
The Japanese multicenter open randomized trial of ursodeoxycholic acid prophylaxis for hepatic veno-occlusive disease after stem cell transplantation. [2000.05]
Enhancement of ursodeoxycholic acid bioavailability by cross-linked sodium carboxymethyl cellulose. [2000.04]
Long-term effects of ursodeoxycholic acid in primary biliary cirrhosis: results of a double-blind controlled multicentric trial. UDCA-Cooperative Group from the Spanish Association for the Study of the Liver. [2000.04]
Evaluation of ursodeoxycholic acid bioavailability from immediate- and sustained-release preparations using gas chromatography-mass spectrometry and high-performance liquid chromatography. [2000.02]
Interferon and ursodeoxycholic acid combined therapy in chronic viral C hepatitis: controlled randomized trial in 203 patients. [2000.01]
Prevention of biliary stent occlusion by ursodeoxycholic acid plus norfloxacin: a multicenter randomized trial. [2000.01]
Effects of ursodeoxycholic acid on splanchnic and systemic hemodynamics. A double-blind, cross-over, placebo-controlled study in healthy volunteers. [2000]
Ursodeoxycholic acid has no influence on function after restorative proctocolectomy in ulcerative colitis. [1999.12]
Ursodeoxycholic acid as adjunctive therapy for problematic type 1 autoimmune hepatitis: a randomized placebo-controlled treatment trial. [1999.12]
Long-term treatment of chronic hepatitis C with ursodeoxycholic acid: influence of HCV genotypes and severity of liver disease. [1999.10]
Combined ursodeoxycholic acid and glycyrrhizin therapy for chronic hepatitis C virus infection: a randomized controlled trial in 170 patients. [1999.10]
Optimum dose of ursodeoxycholic acid in primary biliary cirrhosis. [1999.10]
Oral budesonide and ursodeoxycholic acid for treatment of primary biliary cirrhosis: results of a prospective double-blind trial. [1999.10]
Effect of ursodeoxycholic acid administration in patients with acute viral hepatitis: a pilot study. [1999.09]
The effect of ursodeoxycholic acid on the florid duct lesion of primary biliary cirrhosis. [1999.09]
Effect of pretransplantation ursodeoxycholic acid therapy on the outcome of liver transplantation in patients with primary biliary cirrhosis. [1999.07]
Ursodeoxycholic acid and endothelial-dependent, nitric oxide-independent vasodilatation of forearm resistance arteries in patients with coronary heart disease. [1999.06]
Biliary bile acids in primary biliary cirrhosis: effect of ursodeoxycholic acid. [1999.06]
Comparison of three doses of ursodeoxycholic acid in the treatment of primary biliary cirrhosis: a randomized trial. [1999.05]
Utilization of the Mayo risk score in patients with primary biliary cirrhosis receiving ursodeoxycholic acid. [1999.04]
Effect of ursodeoxycholic acid in acute viral hepatitis. [1999.04]
Histopathological study of primary biliary cirrhosis and the effect of ursodeoxycholic acid treatment on histology progression. [1999.04]
Effect of long term simvastatin administration as an adjunct to ursodeoxycholic acid: evidence for a synergistic effect on biliary bile acid composition but not on serum lipids in humans. [1999.04]
Long-term ursodeoxycholic acid delays histological progression in primary biliary cirrhosis. [1999.03]
Differences in the metabolism and disposition of ursodeoxycholic acid and of its taurine-conjugated species in patients with primary biliary cirrhosis. [1999.02]
Clinical significance of serum bilirubin levels under ursodeoxycholic acid therapy in patients with primary biliary cirrhosis. [1999.01]
Cost-effectiveness of ursodeoxycholic acid therapy in primary biliary cirrhosis. [1999.01]
A randomised placebo-controlled trial of ursodeoxycholic acid and S-adenosylmethionine in the treatment of intrahepatic cholestasis of pregnancy. [1998.11]
Triple therapy with ursodeoxycholic acid, prednisone and azathioprine in primary biliary cirrhosis: a 1-year randomized, placebo-controlled study. [1998.11]
A randomized trial in primary biliary cirrhosis comparing ursodeoxycholic acid in daily doses of either 10 mg/kg or 20 mg/kg. Dutch Multicentre PBC Study Group. [1998.10]
Ursodeoxycholic acid therapy for primary sclerosing cholangitis: results of a 2-year randomized controlled trial to evaluate single versus multiple daily doses. [1998.09]
Relationship between biliary and serum bile acids and response to ursodeoxycholic acid in patients with primary biliary cirrhosis. [1998.09]
A prospective, randomized, double-blind trial evaluating the efficacy of ursodeoxycholic acid in prevention of liver transplant rejection. [1998.07]
Ursodiol prophylaxis against hepatic complications of allogeneic bone marrow transplantation. A randomized, double-blind, placebo-controlled trial. [1998.06.15]
A combination therapy with simvastatin and ursodeoxycholic acid is more effective for cholesterol gallstone dissolution than is ursodeoxycholic acid monotherapy. [1998.06]
Autoimmune conditions associated with primary biliary cirrhosis: response to ursodeoxycholic acid therapy. [1998.06]
Treatment of chronic hepatitis C with interferon with or without ursodeoxycholic acid: a randomized prospective trial. [1998.03]
Cholesterol metabolism and serum and biliary noncholesterol sterols in gallstone patients during simvastatin and ursodeoxycholic acid treatments. [1998.03]
[Recurrence of vesicular microlithiasis. Controlled study with different dosis of ursodeoxycholic acid] [1998]
Ursodeoxycholic acid increased bile flow and affects bile composition in the early postoperative phase following liver transplantation. [1998]
|
